Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer SAB to provide meaningful guidance as the company begins a first-in-human (FIH) clinical trial of their proprietary,...
ALPHEUS MEDICAL CLOSES $16M IN SERIES A FINANCING FOR NOVEL GLIOMA BRAIN CANCER TREATMENT Funds to support first-in-human (FIH) clinical trial of the company’s proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas OAKDALE,...
